OR WAIT null SECS
February 01, 2022
Experience is an invaluable asset for outsourcing partners, particularly as more challenging method development services are in demand.
Shifting demands from industry innovators is leading to an increased need for flexible and agile outsourcing partners offering broad and integrated models.
August 05, 2021
The CRO market will see greater consolidation by both financial buyers looking to consolidate smaller players and larger CRO players wanting to expand into value-added specialty service areas.
June 24, 2021
The companies have entered into an agreement to develop processes for a novel immunotherapy protein.
June 01, 2021
Outsourcing method development offers multiple benefits to companies, including access to experience and expertise, streamlined costs, and development time efficiencies.
July 02, 2020
Manufacturers and the US government are investing heavily in traditional and non-traditional forms and materials to ensure supplies of containers and delivery devices for COVID-19 treatments and vaccines.
March 01, 2020
Contract service organizations can offer biopharma companies early insight into dangers that may hinder a drug’s later development.
March 20, 2019
Alcami Biologics formed to meet market demands for biological drug development services.
December 14, 2018
The merged companies will provide histopathology services in the research and pre-clinical therapeutics markets.
November 26, 2018
ADC Biotechnology will invest downstream formulation, fill/finish capabilities, and Lock-Release conjugation technology.